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Living organisms exposed to sunlight
have developed mechanisms to repair
the damage that UVR induces in their
DNA. These DNA repair systems are
present in most life forms including
bacteria, yeast, rodents, and mammals.
Three rare human genetic diseases
have defects in the DNA repair system
called nucleotide excision repair
(NER). Patients with xeroderma pig-
mentosum (XP) have defective NER
and a more than 10,000-fold increased
frequency of skin cancer, whereas
patients with Cockayne syndrome (CS)
or with trichothiodystrophy (TTD)
have NER defects without increase in
cancer. These are strikingly different
clinical phenotypes (Figure 1). The
dramatic differences in their manifesta-
tions reflect the complexity of DNA
repair and the broad scope and central
role of DNA repair on preservation of
diverse biological functions. This arti-
cle will review the major milestones in
our understanding of DNA repair and
skin cancer (Table 1). These include
recognition of the clinical diseases,
understanding the types of damage
sunlight causes in the DNA, recogni-
tion of DNA repair in different organ-
isms, discovery of defective DNA
repair in humans, cloning of multiple
human DNA repair genes, and identi-
fication of UV-type mutations in skin
cancer.
THE FIRST HUNDRED YEARS: CLINICAL
DISEASE IDENTIFICATION
Moriz Kaposi made many important
contributions to dermatology in the late
nineteenth century. He moved from
Hungary to Vienna, changed his name
from Moriz Kohn, married the daughter
of Professor Ferdinand Hebra, and
co-authored a famous text with him
(Hebra and Kaposi, 1874). In this early
textbook of dermatology, he presented
an 18-year-old girl with ‘‘xeroderma or
parchment skin’’ (Hebra and Kaposi,
1874). There was an exquisitely
detailed description of the pigmentary
changes of her skin with abrupt cutoff
at sun-shielded sites. She also had eye
involvement. The skin was described
as ‘‘parchment like and wrinkled.’’
This patient died of ‘‘cancer of the
peritoneum.’’ A second patient was a
10-year-old girl who developed a large
‘‘epithelioma’’ of her nose in addition
to lesions on her cheek and upper lip
that were ‘‘fissured tubercle of the size
of a pea,’’ thus suggesting the presence
of skin cancers. XP with neurological
abnormalities was described in 1883
by Albert Neisser from Germany (who
also discovered the bacteria that causes
gonorrhea, Neisseria; Neisser, 1883)
and then again in 1932 by the
Italians, Carlo deSanctis and Aldo
Cacchione (deSanctis–Cacchione syn-
drome; de Sanctis and Cacchione,
1932). The well-studied groups of XP
patients were reported from the US
National Institutes of Health (NIH) in
1974 (15 patients) (Robbins et al.,
1974) (Figure 1a–c) and in 2011 (106
patients) (Bradford et al., 2011), and
from Japan in 1977 (50 patients)
(Takebe et al., 1977) and in 1994
(29 patients) (Nishigori et al., 1994).
An extensive literature review in 1987
described clinical features of 830 XP
patients (Kraemer et al., 1987). XP
patients under 20 years of age were
found to have a more than 10,000-fold
increased risk of development of skin
cancer (basal cell carcinoma, squa-
mous cell carcinoma, or melanoma)
(Kraemer et al., 1994; Bradford et al.,
2011).
Edward Alfred Cockayne, in Eng-
land, reported two siblings (7-year-old
girl and 6-year-old boy) having dwarf-
ism with retinal atrophy and deafness.
Their faces were described as ‘‘small
with sunken eyes... with short, slender
trunks and unduly long legs, and their
feet and hands are too large in propor-
tion.’’ They ‘‘appear to be a little below
the average in intelligence and are far
more excitable and laugh much more
readily than children of normal menta-
lityy’’ (Cockayne, 1936). A follow-up
in 1946 reported that the children had
‘‘deeply sunk eyes and partial absorp-
tion of the orbital fat.’’ Cataracts had
been removed and there was
sunburning and marked weight loss
(Cockayne, 1946). In 1992, Martha
Nance and Susan Berry in the United
States (Nance and Berry, 1992) pub-
lished a comprehensive literature
review of 140 CS patients. These
patients frequently had poor growth
and neurologic abnormality, sensori-
neural hearing loss, cataracts, pigmen-
tary retinopathy, photosensitivity, and
dental caries (Figure 1d). The mean age
at death was 12.5 years. There were no
reports of cancer.
TTD was initially described by Chong
Hai Tay (Tay, 1971) as ‘‘ichthyosiform
E8 SEPTEMBER 2014 MILESTONES | CUTANEOUS BIOLOGY
erythroderma, hair shaft abnormalities,
mental and growth retardation,’’ a new
recessive disorder, in three children in a
Chinese family in Singapore. The hair
shafts were easily broken and showed
pili torti and trichorrhexis nodosa-like
defects and polarized microscopy
revealed an alternating pattern of light
and dark transverse bands. This ‘‘tiger
tail banding’’ along with low sulfur
content was also described in the
United States by Howard Baden
(Baden et al., 1976), and by Vera Price
(Price et al., 1980) who gave the
disorder the name trichothiodystrophy
(sulfur-deficient brittle hair). A
comprehensive review of the literature
from the NIH reported on 112 published
TTD cases (Faghri et al., 2007). TTD
patients commonly had developmental
delay/intellectual impairment, short
stature, ichthyosis, abnormal birth
characteristics, ocular abnormalities
including juvenile cataracts, infections,
and photosensitivity (Figure 1e and f).
Surprisingly, there was a high frequency
of maternal pregnancy complications.
TTD patients had a high mortality with a
20-fold increased risk of death under the
age of 10 years. There were no reports of
cancer in classical TTD patients; how-
ever, patients who have both TTD and
XP (the XP/TTD complex) had increased
risk of skin cancer (Broughton et al.,
2001).
THE 1950S–1960S: DISCOVERY THAT UV–
DNA PHOTOPRODUCTS CAUSE DNA
DAMAGE
In 1953, James Watson and Frances
Crick in England published the helical
structure of nucleic acids in DNA
(Watson and Crick, 1953). After 7
years, Rob Buekers and W Berands in
the Netherlands (Beukers and Berends,
1960) reported that UV irradiation
(254 nm) of a frozen solution of
200 µm
Figure 1. Diverse clinical phenotypes of the DNA repair disorders. (a) Xeroderma pigmentosum (XP) patient (XP1BE), age 28 years, has evidence of advanced
UV damage including lentiginous hyperpigmentation with hypopigmented areas, clouding of the corneas of the eyes, damage to the eyelids, atrophy and
telangiectasias of the lips, and scarring from multiple surgeries for basal cell carcinomas, squamous cell carcinomas, and melanomas. She died at age 49 years of
widespread metastatic uterine adenocarcinoma (Lai et al., 2013). Her cells are in XP complementation group C with 15% to 25% of normal unscheduled DNA
synthesis (UDS) (see more details in Robbins et al., 1974). (b) XP variant (XP4BE), age 27 years, has relatively unpigmented scars at sites of grafts from uninvolved
skin used to cover sites of cancer surgeries. He had multiple skin cancers and died at age 27 years from widely metastatic melanoma (Wang et al., 2010). His
cells had normal UDS. He was the first XP variant patient described (see more details in Robbins et al., 1974). (c) XP/Cockayne syndrome (CS) complex patient
(XP11BE), age 28 years, has the sunken eyes, wizened facial features of CS in association with the lentiginous hyperpigmentation, and hypopigmentation of XP.
She had multiple skin cancers. She died at age 33 years of possible arteriosclerosis. Her cells are in XP complementation group B with 3% to 7% of normal UDS.
She was the first XP/CS complex patient described (see more details in Robbins et al., 1974). (d) CS patient (CS507BE), age 7 years, has sunken eyes of CS. She
has microcephaly, markedly short stature, developmental delay, sensorineural hearing loss, bilateral optic atrophy with retinal degeneration, and sun sensitivity.
She is fed with a g-tube. She died at age 9 years. (e) Trichothiodystrophy (TTD) patient (TTD351BE), age 9 years, with short, brittle hair, sparse eyebrows, bright
smile, and happy, socially interactive demeanor characteristic of TTD. He died at age 15 years of prolonged complications following hip surgery. His cells are in
XP complementation group D with 115% UDS (see more details in Boyle et al., 2008). (f) Microscopic appearance of hair from TTD patients. Tiger tail banding
of the hair shafts viewed under polarized microscopy is characteristic of TTD. Arrows show areas of sharp breaks (trichoschisis) in the hair shafts (see more
details in Liang et al., 2006). All patients, or their parents, provided written permission for publication of their images. Previously published images are used with
permission.
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thymine in water produced an irradi-
ation product: the thymine dimer with
the dimers joined covalently with a
cyclobutane bond—the cyclobutane
pyrimidine dimer (CPD) (50 years later,
the theories and experiments that were
used to make this seminal discovery
were recollected by one of these scien-
tists (Beukers et al., 2008)). These
UV-induced photoproducts could be
repaired. Although photoreactivation,
which directly reverses the CPD in
DNA in the presence of long wave-
length (UVA or visible) light, was
known since the 1940s (Dulbecco,
1949; Kelner, 1949), other scientists
in the United States found that yeast
contained photoreactivating enzyme
(Wulff and Rupert, 1962); Cook, 1967).
Reginald Deering and Richard
Setlow in the United States (Deering
and Setlow, 1963) reported that
with longer wavelength, UV (280 nm)
thymine dimers were formed, whereas
with shorter wavelengths (239 nm) the
reaction could be reversed (photo-
reversal). Using this information the
husband and wife team of Richard
and Jane Setlow performed a series of
elegant experiments that showed a
biological effect of thymine dimers
(Setlow and Setlow, 1962). They
demonstrated inactivation of transfor-
ming activity of DNA in bacteria and
phage by 280 nm UV treatment and its
reactivation by treatment with 239 nm
UV. In 1963, Setlow et al. demon-
strated that one thymine dimer was
sufficient to inactivate replicating
DNA in bacteria (Setlow et al., 1963).
Importantly, this same study reported
that there were resistant strains that
were able to overcome the block. This
was an early suggestion that repair of
DNA damage might occur (Setlow
described this early research in a
2000 lecture in the NIH DNA Repair
Interest Group video conference series
‘‘Reflections on how I was led into and
onto DNA repair’’ http://videocast.nih.
gov/launch.asp?10600).
The DNA photoproducts were found
to involve pyrimidines and not purines.
CPD were found with T¼T and T¼C.
A third thymine containing photo-
product was later reported by the US
scientists, Varghese and colleagues—
the thymine–cytosine 6-4 photoproduct
(6-4PP) (Varghese and Wang, 1967;
Varghese and Patrick, 1969).
THE 1960S: DNA REPAIR DISCOVERED IN
BACTERIA
In 1964 in the United States, Richard
Boyce and Paul Howard-Flanders
(Boyce and Howard-Flanders, 1964)
and Setlow and William Carrier
(Setlow and Carrier, 1964) indepen-
dently reported that UV-resistant strains
of E. coli remove thymine dimers from
their DNA whereas sensitive strains do
not. These papers suggested that a
DNA repair process was involved in
recovery from UV treatment. This
process was called ‘‘dark repair’’ as
removal occurred without additional
light exposure, in contrast to
photoreversal that required 240 nm
UV and to enzymatic photoreacti-
vation by photoreactivating enzyme
that required long wavelength or
visible light.
Phillip Hanawalt, after receiving
his degree as the first graduate student
of Richard Setlow at Yale University
(Setlow, 2005), took a postdoctoral
Table 1. Timeline for milestones of DNA repair and skin cancer research
Dates Milestone
Clinical descriptions of diseases:
1874 Xeroderma pigmentosum (XP)
1936 Cockayne syndrome (CS)
1971 Trichothiodystrophy (TTD)
1950–1969 Identification of UV-induced DNA photoproducts: cyclobutane pyrimidine dimers (CPD), 6-4 pyrimidine-pyrimidone photoproducts (6-4PP)
1960s Recognition of DNA repair in bacteria, repair replication
1968 Reduced nucleotide excision repair (NER) in XP
1960–1979 Defective DNA repair in humans: XP and CS complementation groups
1971–1975 Description of XP variant: normal NER with defective postreplication repair
1974 Description of XP/CS complex
1985 Identification of transcription coupled repair (TCR): removal of UV-induced CPD from active genes is more efficient than from the genome
overall
1980–1999 Cloning of human NER repair genes
1993 Dual role of XPB and XPD helicases in NER and in transcription as part of basal transcription factor IIH (TFIIH)
1928 UV induction of skin cancer in mouse models
1941 Quantitation of UV induction of skin cancer in mice
1977 UV-treated thyroid cells produce tumors in fish, reduced by photoreactivation
1991 UV-type mutations in p53 tumor suppressor gene in squamous cell carcinomas of human skin
1994 Sunburn cells are apoptotic keratinocytes with inactivating mutations in p53. Sunlight-inducted mutations in p53 in skin act as both a tumor
initiator and a tumor promoter
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fellowship in Denmark. There, he
learned about BrdU—a nucleic acid
analog of higher density than thymine.
After returning to the United States, at
Stanford University, Hanawalt used
BrdU to analyze the location of newly
synthesized DNA in bacteria following
removal of thymine dimers. In cesium
chloride density gradients, newly
synthesized DNA containing BrdU
would migrate at a different density
than the parental DNA containing
thymine. They performed BrdU pulse
labeling experiments on UV-treated
bacterial cells. A statement in the
classic 1964 paper contains the basis
of our current knowledge of DNA
repair: ‘‘Our findings are consistent
with the view that in ultraviolet-resis-
tant organisms a mechanism for repair
replication exists in which damaged
single-strand regions of the chromo-
some can be excised and replaced,
using the undamaged DNA strand as
template’’ (Pettijohn and Hanawalt,
1964) (see also the 2002 video of
Hanawalt’s description of early DNA
repair studies ‘‘Half a Century of DNA
Repair: an Historical Perspective; http://
videocast.nih.gov/launch.asp?10587).
The search for the enzymes that
carried out DNA repair yielded inter-
esting results. Setlow reported an endo-
nuclease in T4 phage that cut DNA at
cyclobutane dimers (Setlow et al.,
1970). Intensive research by many labs
found that removal of UV photo-
products in bacteria was primarily
accomplished by the multiprotein
UvrABC system (reviewed by a pioneer
scientist, Larry Grossman in the United
states (Grossman et al., 1988) (see
the 1999 video of Grossman ‘‘Four
decades of DNA repair: from popula-
tions of molecules to populations of
people’’ http://videocast.nih.gov/launch.
asp?10595). However, this is a different
DNA repair system from that in higher
organisms.
THE 1960S–1970S: DNA REPAIR DEFECTS
IN HUMAN CELLS
In 1964, Donald Rasmussen and
Robert Painter in the United States
reported evidence of repair replication
in mammalian cells by finding increa-
sed incorporation of radioactive thymi-
dine following UV exposure to cultured
hamster and human (HeLa) cells
(Rasmussen and Painter, 1964). By
use of autoradiography, they also
showed that, unlike the scheduled
S-phase DNA synthesis, this post-UV
thymine incorporation occurs in nearly
all cells in all phases of the cell cycle
and thus is ‘‘unscheduled DNA
synthesis’’ (UDS).
James Cleaver, working as a postdoc
in the Painter laboratory, read a news-
paper article about patients with sun
sensitive disorder, XP, who had increa-
sed skin cancer risk. In 1968, he
reported that cultured skin cells from
XP patients had reduced post-UV repair
replication (measured by use of H3-
BrdU in cesium chloride gradients) and
reduced UDS (measured by autoradio-
graphy) compared cells from normal
donors (Cleaver, 1968). This seminal
result thus linked defective DNA repair
to increased cancer risk (see 2001
video of Cleaver ‘‘Mending human
genes’’ http://videocast.nih.gov/launch.
asp?10561).
Setlow et al. wrote in 1969 that they
based their work on previous studies in
bacteria that found that the mechanism
of excision of UV induced dimers is
a multistep process involving ‘‘(1) a
single-strand break on one side of
a dimer; (2) dimer excision as a result
of a second break on the same strand;
(3) repair replication which fills in the
resulting gap; and (4) closure of the gap
by ligase action’’ (Setlow et al., 1969).
In an analogous manner, they reported
that cultured skin cells from an XP
patient did not remove UV-induced
thymine dimers from their DNA and
did not perform the first step involving
DNA strand breaks required for
excising dimers. This finding pointed
to dimers as playing an important role
in UV-induced skin cancer in humans.
In Rotterdam, The Netherlands, the
group led by Dirk Bootsma fused
cultured fibroblasts from XP patients
with neurological abnormalities with
cultured fibroblasts from XP patients
without these abnormalities. They
then performed post-UV UDS assay
with autoradiography. They found
that certain combinations of cells
had increased UDS, indicating that
each cell provided what the other was
lacking—they complemented the
repair defect (De Weerd-Kastelein
et al., 1972). This implied that each
complementation group had a different
genetic defect.
In the United States, Jay Robbins
began studying patients with XP at
the NIH by examining patients with
different clinical features (Robbins
et al., 1974) (Figure 1a–c). There were
eight XP patients with abnormalities
confined to their skin and eyes. Five XP
patients, in addition, had progressive
neurological degeneration. One XP
patient had skin and eye abnormalities
plus neurological degeneration with
extremely short stature and immature
sexual development—features of a
second disorder, CS—the first patient
described with the XP/CS complex
(Figure 1c). All 14 of these XP patients
had reduced UDS. Cell fusion studies
revealed that they represented four XP
complementation groups (Kraemer
et al., 1975a). As the cells assigned
to each complementation group had
a similar range rate of residual DNA
repair, the XP complementation groups
were named in order of increasing
residual repair (XP-A to XP-D)
(Kraemer et al., 1975a). An arrange-
ment between the NIH scientists and
the group in Rotterdam set the model
for collaboration in the early stages of
these investigations that has followed
to the present day. These groups
exchanged cell lines and determined
that there were five XP DNA repair
complementation groups (XP-A to
XP-E) (Kraemer et al., 1975b). In
1979, a Japanese group reported a
patient with low UDS and mild
disease, forming complementation
group XP-F (Arase et al., 1979). A
Dutch group reported another patient
with low UDS and no skin cancers
forming complementation group XP-G
(Keijzer et al., 1979) (see also the 2010
video of Kenneth Kraemer and Vilhelm
Bohr ‘‘History of DNA repair: Four
decades of DNA repair at NIH and
the first twenty-five years of the DNA
Repair Interest Group’’ http://
videocast.nih.gov/launch.asp?15954).
One of the NIH patients (XP4BE) had
severe disease but normal UDS in skin
and blood cells (Burk et al., 1971a, b;
Robbins and Burk, 1973; Robbins
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et al., 1974) (Figure 1b). These patients
have been called XP variants (Cleaver,
1972). In 1975, Alan Lehmann and
colleagues in the United Kingdom repor-
ted that XP variant cells had normal NER
but defective post-replication repair,
a process of DNA synthesis after
UV irradiation (Lehmann et al., 1975).
They also showed that, unlike normal
cells, this process was inhibited
by caffeine. see also the 2013 video
of Lehmann ‘‘Human DNA Repair
Disorders: A Historical Perspective
1968–2013’’ http://videocast.nih.gov/
launch.asp?17965).
In 1977, R Schmickel and colleagues
in the United States reported that
cultured skin fibroblasts from two
patients with CS were hypersensitive
to killing by UV but had normal survi-
val after X-ray treatments (Schmickel
et al., 1977). CS cells had normal rate
of removal of thymine dimers
(Schmickel et al., 1977) and normal
UDS (Andrews et al., 1978). In 1981, a
Japanese group led by Kiyoji Tanaka
found that CS cells had delayed
recovery of DNA synthesis following
UV exposure. They found that certain
pairs of CS cells when fused would
correct this defect forming comple-
mentation groups CS-A and CS-B
(Tanaka et al., 1981). Lehmann in
England reported that certain pairs
of CS when fused would correct a
defect in post-UV recovery of RNA
synthesis (Lehmann, 1982). This poin-
ted to a defect in repair of active genes
in CS.
In 1985, Vilhelm Bohr and Philip
Hanawalt reported that in hamster
cells, removal of UV-induced pyrimi-
dine dimers from an active gene was
more efficient than from the genome
overall, i.e., preferential repair of
actively transcribing genes (transcrip-
tion coupled repair) (Bohr et al., 1985).
The following year, they demonstrated
that post-UV survival of human cells
correlated with efficient transcription
coupled repair (Bohr et al., 1986). Cells
from an XP-C patient and hamster cells
had similar overall repair levels.
However, the XP-C cells had reduced
repair of the dihydrofolate reductase
(DHFR) gene and low survival,
whereas the hamster cells had high
repair of DHFR and normal survival.
European researchers reported in 1990
that CS cells had defective post-UV
repair transcription coupled repair
and normal repair of nontranscribed
regions of the genome (Venema et al.,
1990).
A letter to the editor of the Journal of
the American Academy of Dermatol-
ogy in 1985 by D. van Neste and
colleagues from Belgium and France
reported that cells from a photosensi-
tive TTD patient had reduced post-UV
DNA excision repair (Van Neste et al.,
1985). The following year, researchers
from Italy reported that cells from four
photosensitive TTD patients were in XP
complementation group D (Stefanini
et al., 1986).
THE 1980S–1990S: CLONING DNA REPAIR
GENES
The XP complementation groups that
were reported in the 1970s were
believed to represent different genes
that when mutated would underlie XP
clinical features. Identifying these
genes turned out to be a difficult task.
As working with human cells was very
difficult, and DNA repair systems were
present in most organisms, in the 1980s
scientists in different parts of the world
developed other model systems that
were more amenable to experimen-
tation.
Researchers in California mutagen-
ized hamster cells with ethyl methane
sulfate and were able to isolate 450
UV-sensitive mutant clones out of
B700,000 clones screened utilizing
several selection methods (Busch
et al., 1980; Thompson et al., 1980)
(see the 2004 video of Larry Thompson
‘‘Chinese Hamster Cells and DNA
Repair—a Long Lasting Affair’’ http://
videocast.nih.gov/launch.asp?12877).
In 1984, the first human DNA repair
gene was cloned by researchers in
the Netherlands. This human gene
corrected the defect in hamster group
1 and was named ERCC1 (Excision
Repair Cross Complementing 1)
(Westerveld et al., 1984). It was not
until 2007 that a patient was reported
to have a defect in ERCC1 (Jaspers
et al., 2007). This severely affected
child had marked developmental delay
with features of a CS-like disorder,
cerebro-ocular-facial syndrome, and
died at age 14 months.
The group in the United States that
generated the clones of UV-sensitive
hamster cells succeeded in correcting
the NER defect in UV-sensitive hamster
complementation group 2—this gene
was called ERCC2 (Weber et al., 1988).
They then demonstrated that the
addition of the ERCC2 gene to the
mutant hamster cells corrected a defect
in excision of CPD (Regan et al., 1990).
The husband and wife team of Louise
and Satya Prakash in the United States
studied methyl methanesulfonate–
induced mutants in yeast and isolated
22 complementation groups of radia-
tion-sensitive mutants (Prakash and
Prakash, 1977). The human ERCC2
gene was found to have high homo-
logy to the yeast NER protein RAD3
(Weber et al., 1990). ERCC2 was
later found to be defective in cells in
XP complementation group D from
patients with XP (Takayama et al.,
1995) or with TTD (Takayama et al.,
1996).
In 1989, in Japan, after screening
4100,000 colonies, Kiyoji Tanaka
succeeded in isolating a clone of
mouse DNA that corrected the UV
hypersensitivity of an XPA cell line
(Tanaka et al., 1989). The following
year, he reported cloning of the human
gene on chromosome 9 that corrected
the XP complementation group A cells
(Tanaka et al., 1990) and described a
common founder splice mutation that
was present in 20 of 21 Japanese XP-A
patients (Satokata et al., 1990). The
Japanese researchers used embryonic
stem cells to establish XPA-deficient
mice. These mice had defective NER
and were highly susceptible to UVB or
chemical (9,10-dimethyl-1,2-benz[a]
anthracene)-induced skin carcino-
genesis (Nakane et al., 1995). This
study clearly provided in vivo evidence
that XPA protein protects mice from
carcinogenesis induced by UV or
chemical carcinogens.
The human ERCC3 gene was cloned
by its ability to correct UV sensitivity
and post-UV UDS defect in a hamster
mutant in complementation group 3
(Weeda et al., 1990a). ERCC3 was
localized to human chromosome 2
(Weeda et al., 1990a). ERCC3 was
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reported to correct the NER defect in
cells from the only patient in XP
complementation group B (Weeda
et al., 1990b), a woman with features
of both XP and CS (Figure 1c) (Robbins
et al., 1974). Analysis of the 782 amino
acid sequence of ERCC3 predicted that
it would function as a helicase to
unwind DNA (Weeda et al., 1990b).
The human ERCC5 gene that cor-
rected the defect in hamster mutant
complementation group 5 was isolated
by a group from Los Alamos (Mudgett
and Macinnes, 1990) and later repor-
ted to have homology to the yeast
RAD proteins (Saccharomyces cerevi-
siae RAD2 and Schizosaccharomyces
pombe rad13) (Macinnes et al., 1993).
In Japan, the group led by Masaru
Yamaizumi reported that the ERCC5
gene corrected the post-UV UDS
defect and increased post-UV cell
survival in human XP complemen-
tation group G cells (Shiomi et al.,
1994).
Researchers from the Netherlands
isolated the human ERCC6 gene that
corrected the defect in hamster com-
plementation group 6 (Troelstra et al.,
1990). Interestingly, the mutant ham-
ster cells have deficient repair of CPD
but normal repair of 6-4PP. In 1992,
the same group reported that ERCC6 is
a putative helicase that is defective in
CS-B cells and is involved in preferen-
tial repair of active genes (Troelstra
et al., 1992). The gene that is defective
in CS-A cells was identified by a group
in the United States (Henning et al.,
1995). This gene encodes a tryptophan-
aspartic acid (WD) repeat that interacts
with CS-B protein and also with the
basal transcription factor IIH, TFIIH. By
2010, there were reports of mutations
in 84 CS kindreds with 62% having
mutations in the CSB (ERCC6) gene
(Laugel et al., 2010).
Randy Legerski in the United States
used a library of human DNA that was
cloned in an Epstein–Barr virus expres-
sion vector to isolate the XPC gene in
1992 (Legerski and Peterson, 1992). This
group then reported different mutations
in the XPC gene in five XP-C patients
(Li et al., 1993). The XPC gene product,
complexed with HR23B, was shown to
initiate global genome repair of UV
damage (Sugasawa et al., 1998).
Correction of hamster complementa-
tion group 4 was accomplished by
use of a human cosmid library and
isolation of the ERCC4 gene that was
localized to human chromosome
16p13.13–p13.2. The transformed cells
had increased ability to excise thymine
dimers from a plasmid in an in vitro
assay (Thompson et al., 1994). In
human cells this protein was shown to
correct the defect in XP-F cells and to
be in close association with ERCC1, the
protein that corrects the defect in
hamster complementation group 1
(Sijbers et al., 1996). The complex
serves as a structure-specific endo-
nuclease that makes the 50 incision in
NER (Sijbers et al., 1996).
Using a UV-treated 8-nucleotide
poly-dT fragment as bait, in 1988
Gilbert Chu in the United States iso-
lated two factors that bind to damaged
DNA (DDBF1 and DDBF2) but were
absent from cells in XP complementa-
tion group E (Chu and Chang, 1988).
The complementary DNA for the genes
encoding these factors (DDB1 and
DDB2) was cloned by Stuart Linn’s
group in the United States and loca-
lized to human chromosome 11
(Dualan et al., 1995). The protein
products of these genes are a hetero-
dimer of 127-kDa and 48-kDa sub-
units. The Linn group identified mis-
sense mutations in the p48 subunit on
patients in XP complementation group
E (Nichols et al., 1996) (see the 2006
video Linn ‘‘ Life in the serendipitous
lane: excitement and gratification in
studying DNA repair’’ http://videocast.
nih.gov/launch.asp?13303). Examina-
tion of cell lines that had been classi-
fied as XP-E revealed that not all
had mutations in DDB2. Detailed
investigations by scientists in the
United States and Italy revealed that
the DDB2-negative cells had defects in
other genes and that true XP group E
patients had defects in DDB2 (Rapic-
Otrin et al., 2003). Interestingly, wild-
type rodent cells are defective in DDB2
and have reduced global genome
repair, causing some to question their
use as models for carcinogenesis in
humans (Tang et al., 2000). DDB2 was
reported to be involved in global geno-
mic DNA repair and its expression was
dependent on p53, thereby linking the
post-UV p53 responses such as cell
cycle arrest and apoptosis to DNA
repair (Hwang et al., 1999). DDB2 is
a ubiquitin ligase that is regulated in
response to DNA damage (Groisman
et al., 2003).
In 1999, two groups using different
approaches independently came to the
same conclusions about the defective
gene in the XP variants with clinical XP
but normal NER (see above and
Figure 1b) (Robbins et al., 1974). The
Prakash group in the United States
working with S. cerevisiae yeast found
that the RAD30 gene functions in error-
free bypass of UV lesions. They found
that RAD30 encodes a DNA poly-
merase, Pol eta, that can efficiently
replicate past a thymine dimer. They
reported that the human homolog
(hRAD30) is defective in XP variant
patients (Johnson et al., 1999). (see the
2003 video of Prakash ‘‘Translesion
synthesis DNA polymerases of yeast
and humans’’ http://videocast.nih.gov/
launch.asp?10602). In Japan, a group
led by Fumio Hanaoka used a cell-free
assay system to isolate a DNA poly-
merase from human cells that conti-
nues replication on damaged DNA.
They found that this polymerase, the
human homolog of yeast Rad30 protein
(Pol eta), was defective in XP variant
cells and that recombinant Pol eta
could correct the defect in DNA
replication (Masutani et al., 1999).
Subsequent research discovered that
there are several similar DNA poly-
merases (Y-family polymerases) that
bypass lesions rather than removing
them (reviewed in Sale et al., 2012)
(see also the 1999 video by Roger
Woodgate ‘‘Translesion DNA synthesis:
From mutations in bacteria to the xero-
derma pigmentosum variant phenotype
in humans’’ http://videocast.nih.gov/
launch.asp?10601).
Following the identification of the
genes involved in NER, the next
challenge was to determine how they
worked together to excise DNA
damage. An early surprise was that
the ERCC3 gene (XP-B complemen-
tation group) was an adenosine triphos-
phate–dependent DNA helicase and a
carboxy-terminal domain kinase that
was involved in NER and also as part
of the basal transcription factor IIH,
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TFIIH, that is required for polymerase II
class transcription (Schaeffer et al.,
1993). This finding provided a strong
link between DNA repair and trans-
cription. One additional feature of this
link relates to the fact that transcription
is necessary for survival. Therefore,
mutations in the genes involved in
TFIIH (ERCC3 (XP-B) and ERCC2
(XP-D)) leading to complete loss of
activity would be lethal. This find-
ing might also provide an explanation
for the different phenotypes among
patients with mutations in ERCC3 and
ERCC2. Some mutations would prima-
rily affect NER leading to XP with
increased cancer risk, whereas others
would affect transcription leading to
developmental defects such as short
stature and developmental delay in XP/
CS complex and in TTD (reviewed in
Compe and Egly, 2012).
How the NER proteins interact was
shown in elegant experiments by a
group from the Netherlands in 2001.
They performed local UV irradiation of
cultured fibroblasts through isopore
polycarbonate filters with pore dia-
meters of 3mm that are smaller than
the size a cell nucleus. This was
followed by serial immunostaining
of normal or XP cells with different
defects at different times after UV
exposure. They used antibodies to
CPD, 6-4PP, or to different NER pro-
teins (Volker et al., 2001). They found
that in normal cells the damage
recognition complex of XPC-hHR23B
was essential for recruitment of all
other NER factors including TFIIH.
XPA was associated relatively later
and was required for anchoring of
ERCC1-XPF endonuclease and for
activation of XPG endonuclease. In
2008 at NIH, this technique was used
to show differences between XP cells
and TTD cells with different defects in
the XPD (ERCC2) gene (Boyle et al.,
2008). The XPC protein was rapidly
localized in all cells. In normal cells,
the other NER proteins (XPB, XPD,
XPG, XPA, and XPF) were rapidly
recruited and redistributed by
24 hours. In the XP cells, recruitment
of the other NER proteins was delayed
and persisted for 24 hours, suggesting
their failure to be removed may
function as a block to bypass repair.
In TTD cells, recruitment of NER
proteins was reduced and remained
low at 24 hours. The TTD cells
removed 6-4PP but not CPD, whereas
the XP cells removed neither. These
differences in NER protein recruitment
and removal may be related to the
differences in cancer susceptibility of
the XP and TTD patients.
MECHANISMS OF UV-INDUCED CANCER
According to a detailed history of
photobiology of the skin by Frederick
Urbach, P Donald Forbes, Ronald
Davies, and Daniel Berger from Phila-
delphia published in 1976, UV was
discovered in 1801 by F Ritter in
Germany (Urbach et al., 1976). They
attribute the discovery that UV causes
skin erythema to P Charcot in France in
1858 who used electric arcs to
generate UV. They credit the linkage
of UV exposure to increased pigmen-
tation and to skin cancer, as seen
sailors and in patients with XP to P
Unna in Germany in 1894. An early
dermatoepidemiologic study by W
Dubreuilh (1896) reported that in the
Bordeaux region of France, keratoses
and skin cancers were frequently
observed in the workers in the
vineyards, but only occasionally in
the nearby city dwellers. A seminal
paper by Karl Hausser and Wilhelm
Vahle that presented most of the
data that form current understanding
of action spectrum of erythema
and tanning was published in 1927.
Hausser noted that hikes in the
afternoon under the sun had almost
no effect, whereas ‘‘a brief sojourn on
snow at noontime resulted in severe
sunburn.’’ This paper showed that skin
erythema and pigmentation depended
on the wavelength of UV radiation.
The effect was limited to wavelengths
shorter than 320 nm (UVB 280–
320 nm) and variations in the amount
of this UV that passed through the
atmosphere were related to the season
and time of day and explain the
differences in sunburning (an English
translation of this important paper by
Urbach appears in the 1969 classic
book ‘‘The Biologic Effects of Ultra-
violet Radiation – with Emphasis on
the Skin’’ (Hauser and Vahle, 1969)).
Advances in instrumentation and
measurement of the spectral compo-
sition of light resulted in better under-
standing of the factors influencing the
radiation reaching the surface of the
earth including the absorption charac-
teristics of ozone, the angle of the
sun, and scattering of UVB radiation by
particles such as dust, haze, aerosols,
and clouds (Schulze and Grafe, 1969).
The demonstration that UV irradia-
tion of mouse skin produced tumors
was published by GM Findlay in
England in 1928 (Findlay, 1928). He
reported that daily exposure of epilated
back skin of albino mice to UV from
a mercury arc lamp (output from
200nm UV through 1,014 nm infra-
red) produced papillomas and carci-
nomas following 34 to 58 weeks of
exposure. He found that this exposure
period could be shortened by applica-
tion of tar before the UV exposure.
The development of stable sources of
UV and instrumentation enabled long-
term studies of the quantitative mea-
surement of induction of tumors on the
ears of albino mice by Harold Blum
and associates at the US National
Cancer Institute in 1941 (Blum et al.,
1941). These studies indicated that a
single dose of UV was not sufficient
to induce tumors but there was a
‘‘development time’’ before the first
tumors appeared that varied with the
dose used. There was a constant dose–
time relation and reciprocity held until
the dose became too small to produce
tumors during the life of the mice
(Blum, 1969).
Using the Amazon molly fish that
grows in clones, the Setlow group in
New York injected UV irradiated molly
thyroid cells into isogenic recipients.
These cells produced tumors. The
frequency of tumors was reduced by
use of photoreactivation to remove
CPD, thereby providing evidence that
dimers in DNA can give rise to tumors
(Hart et al., 1977). In 1989, using a
platyfish–swordtail hybrid fish model
system, the Setlow group used different
wavelengths of radiation to induce
melanomas. They found that multiple
exposures of 4304 nm resulted in
increased melanoma frequency over
the background level (Setlow, et al.,
1989). These experiments included
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UVA as well as UVB exposure.
A recent review summarized the
evidence that UVA induces CPDs that
are mutagenic and alter cell cycle
regulation (Runger et al., 2012).
Douglas Brash and colleagues in the
United States and Scandinavia exam-
ined squamous cell carcinomas of the
skin from patients from New England
and Sweden (Brash et al., 1991). They
performed DNA sequencing of the p53
tumor suppressor gene and found that a
high frequency (58%) of invasive
squamous cell carcinomas contain
p53 mutations that alter the amino
acid sequence. These mutations had
features of UV mutagenesis including,
occurring exclusively at dipyrimidine
sites, a high frequency of C to T base
substitutions, and having CC to TT
double-base changes. These changes
were different from those found in p53
mutations from internal cancers. In a
follow-up study, this group examined
precancerous actinic keratoses in the
sun-exposed skin of patients from New
England (Ziegler et al., 1994). They
found that p53 mutations were present
in 60% of the actinic keratoses and
29% also had loss of a p53 allele. The
mutations had UV-type features as in
the earlier squamous cell carcinoma
study. Adjacent actinic keratoses
showed clones with different p53
mutations, indicating that they arose
from independent photon events. Irra-
diation of mice resulted in the appea-
rance of ‘‘sunburn cells’’ (apoptotic
keratinocytes) that had mutations in
p53. The sunburn cells were greatly
reduced in p53-negative mice. They
conclude that skin appears to possess
a p53-dependent ‘‘guardian of the
tissue’’ response to DNA damage that
aborts precancerous cells. ‘‘If this
response is reduced in a single cell by
a prior p53 mutation, sunburn can
select for clonal expansion of the p53
mutated cell into an AK. Sunlight can
act twice: as a tumor initiator and a
tumor promoter’’ (Brash describes this
work in the 2001 video lecture presen-
ted to the Royal College of Pathologists
in London http://videocast.nih.gov/
launch.asp?10621).
Since Kaposi’s 1874 description of
patients with XP, it has been a long
road to understanding the role of UV
damage in causing skin cancer and of
DNA repair in skin cancer prevention.
Many questions remain. The precise
clinical genotype/phenotype correla-
tions within the NER-related clinical
syndromes are not well defined. For
some patients with clinical features
diagnostic of XP and TTD, mutations
in known genes have not been found,
suggesting additional genes for discov-
ery. Successful therapeutic interven-
tions targeting correction of the
underlying gene defects have not been
achieved. But the pace of discovery is
quickening, and we are confident that
we will reach these future milestones
faster than the time it has taken us to
arrive at this point from Kaposi’s
observation 140 years ago.
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